Search

Home > In conversation with... > Alexandra Durr on riluzole in patients with spinocerebellar ataxia type 2
Podcast: In conversation with...
Episode:

Alexandra Durr on riluzole in patients with spinocerebellar ataxia type 2
Category: Science & Medicine
Duration: 00:07:55
Publish Date: 2022-02-22 10:00:00
Description:

Alexandra Durr (Paris Brain Institute, Pitié-Salpêtrière Paris, France) discusses the ATRIL study, a randomised trial of riluzole in patients with spinocerebellar ataxia type 2, which is published in the March issue of The Lancet Neurology.

Read the full article:
Safety and efficacy of riluzole in spinocerebellar ataxia type 2 in France (ATRIL)
Total Play: 0